AccessPak for HIV PEP Expanded with Kaletra and Glatiramer Subcutaneous
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Glatiramer Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: glatiramer
Brand name: Copaxone, Glatopa
Synonyms: Glatiramer (injection), Glatiramer Acetate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Glatopa
- AccessPak for HIV PEP Expanded with Kaletra-Glatopa injection
- AccessPak for HIV PEP Expanded with Kaletra-Glecaprevir and pibrentasvir
- AccessPak for HIV PEP Expanded with Kaletra-Gleevec
- AccessPak for HIV PEP Expanded with Kaletra-Glenmax PEB DM
- AccessPak for HIV PEP Expanded with Kaletra-Glenmax PEB DM FORTE
- Glatiramer Subcutaneous-AccessPak for HIV PEP Expanded with Viracept
- Glatiramer Subcutaneous-Accolate
- Glatiramer Subcutaneous-Accretropin
- Glatiramer Subcutaneous-Accucaine
- Glatiramer Subcutaneous-AccuHist Drops
- Glatiramer Subcutaneous-AccuHist PDX Drops